Latest Market Expansion News

AVITA Medical reported a 13% drop in Q3 commercial revenue to $17.1 million but improved its net loss and secured CE Mark approval for RECELL GO in Europe, signaling strategic shifts ahead.

Hansen Technologies has agreed to acquire UK-based Digitalk for approximately A$66.4 million, aiming to boost its recurring revenue and global communications footprint. The deal is expected to be immediately accretive to earnings and completed by year-end 2025.

PEXA Group reported a robust first quarter for FY26, driven by refinancing growth in Australia and rising momentum in the UK market. The company reaffirmed its full-year guidance while advancing key strategic initiatives including platform modernization and a NatWest partnership.

Challenger Limited has provided a detailed update on APRA’s proposed capital standards, highlighting enhanced capital strength and strategic growth opportunities in the life insurance sector.

St George Mining reports exceptional high-grade rare earth and niobium mineralisation at its Araxá Project in Brazil, alongside a strategic US partnership and a significant capital raise to fuel expansion.

Nimy Resources has completed a major drilling campaign confirming high-grade gallium mineralisation and made significant copper-nickel discoveries at its Mons Project in Western Australia, while forging strategic ties with US partners to advance its critical minerals ambitions.

Merino & Co. initiates a new chapter with leadership changes and a strategic partnership to enter China’s premium apparel market, while investing heavily in growth during Q1 FY26.

Ovanti Limited has made significant strides in its U.S. buy now, pay later (BNPL) expansion, securing a major partnership with Shift4 Payments and raising $8 million to fuel growth.

BPH Global Limited secured $1.1 million in a recent placement and reported robust growth in its Indonesian seaweed operations, alongside promising advances in innovative seaweed-based products and strategic regional partnerships.

WA Kaolin Ltd has reported a record-breaking quarter in sales volume and revenue, driven by operational enhancements and expanding market reach across Asia and domestic sectors.

Acrux Limited reports robust revenue growth in Q1 FY26, driven by strong profit share income from recently launched topical pharmaceuticals and a significant R&D tax rebate repayment.

EVE Health Group has taken significant strides in commercialising its women’s and men’s health products Dyspro™ and Libbo™, securing regulatory clearances, first patient prescriptions, and raising $1.1 million to support market expansion.